Xiao-Ling Zhu Selected Research

Xiao-Ling Zhu Research Topics

3	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 01/2016
2	Proteinuria 11/2018 - 12/2013
2	Reperfusion Injury 01/2017 - 01/2009
2	Myocardial Infarction 04/2008 - 05/2007
2	Neoplasms (Cancer) 07/2007 - 05/2007
1	Pain (Aches) 01/2021
1	Postoperative Pain 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Scoliosis 01/2021
1	Postoperative Hemorrhage 01/2021
1	Obesity 12/2020
1	Hyperplasia 12/2019
1	Neointima 12/2019
1	Inflammation (Inflammations) 01/2019
1	Spinal Cord Ischemia 01/2017
1	Gingivitis 11/2016
1	Acute Lung Injury 01/2016
1	IGA Glomerulonephritis (IGA Nephropathy) 04/2015
1	Lung Neoplasms (Lung Cancer) 01/2014
1	No-Reflow Phenomenon 01/2013
1	ST Elevation Myocardial Infarction 01/2013
1	Chronic Renal Insufficiency 05/2011
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2009
1	Brain Ischemia (Cerebral Ischemia) 01/2009
1	Stroke (Strokes) 01/2009
1	Hypertrophy 06/2008
1	Aggressive Periodontitis (Periodontosis) 05/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2007
1	Inferior Wall Myocardial Infarction 05/2007

1	GlucocorticoidsIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Phosphodiesterase InhibitorsIBA 01/2021
1	SmokeIBA 01/2021
1	Vitamin D FDA LinkGeneric 12/2020
1	hydroxide ionIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 12/2019
1	Circular RNAIBA 12/2019
1	Neuropilin-1IBA 12/2019
1	Cannabinoid Receptor AgonistsIBA 01/2019
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2019
1	CreatinineIBA 11/2018
1	NitrogenIBA 11/2018
1	Urea (Carbamide)FDA LinkGeneric 11/2018
1	HMGB1 Protein (HMG1)IBA 01/2017
1	lipoxin A4IBA 01/2017
1	sivelestatIBA 01/2016
1	SodiumIBA 01/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2016
1	Complement C4 (Complement Component 4)IBA 04/2015
1	Insulin-Like PeptidesIBA 01/2014
1	methyl 4-azidophenylacetimidate (APAI)IBA 01/2014
1	ResveratrolIBA 12/2013
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2013
1	Emodin (Archin)IBA 05/2011
1	Messenger RNA (mRNA)IBA 01/2009
1	ThioredoxinsIBA 01/2009
1	tetramethylpyrazineIBA 01/2009
1	Thioredoxin Reductase 1IBA 01/2009
1	Protein Kinase CIBA 06/2008
1	Rosiglitazone (Avandia)FDA Link 06/2008
1	maltoporinsIBA 06/2008
1	Peroxisome ProliferatorsIBA 06/2008
1	Endothelin-1 (Endothelin 1)IBA 06/2008
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2007
1	Glycoproteins (Glycoprotein)IBA 05/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007

3	Therapeutics 01/2021 - 05/2007
2	Percutaneous Coronary Intervention 01/2013 - 05/2007
1	Enhanced Recovery After Surgery 01/2021
1	Length of Stay 01/2021
1	Catheters 01/2017
1	Electroacupuncture 01/2017
1	Aftercare (After-Treatment) 11/2016
1	Drug Therapy (Chemotherapy) 05/2007
1	Thrombectomy 05/2007